CClinicalTrials.gg
Sign In
Status unknownNCT04040283Updated Jul 31, 2019

Platelet-rich Plasma for Menical Tear

An observational study in Platelet-Rich Plasma and Meniscus Lesion, sponsored by University of Malaga. Status unknown at 1 site in Spain. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2019-07-31.

Sponsored by University of Malaga · Observational

The sponsor has not verified this record recently (last verified Jul 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
15
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Meniscal injuries are a common pathology among athletes, and have an impact on the daily or sporting practice of patients. Surgical approach implies sometimes heavy consequences. Platelet-rich-plasma (PRP) has been shown to be effective in accelerating wound healing and tissue regeneration in orthopedic and oral surgery. This clinical trial aims to investigate the safety and efficacy of intraarticular and periferal PRP injection in patients with stable meniscal injury. The pre- and post-interventional clinical outcomes will be compared.

02

Conditions studied

  • Platelet-Rich Plasma
  • Meniscus Lesion

Keywords

  • Growth factors
  • Meniscal injury
03

In context

Lead sponsor

University of Malaga is the lead sponsor of 118 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Skeletally mature patients aged between 18 and 70 years with imaging and clinical diagnosis of meniscus injury and no indication of meniscus repair surgery

Inclusion criteria

  • Skeletally mature patients 18-70 years of age
  • With diagnosis of meniscus injury
  • Single tear of the medial and/or lateral meniscus
  • With no indication of meniscus repair surgery

Exclusion criteria

Exclusion Criteria:

  • Prior history of multiple ligaments injury, associated significant ligament instability: Grade III MCL, Grade III PCL, or ACL deficient knee
  • Prior history of knee surgery
  • Discoid meniscus
  • Osteoarthritic changes (Kellgren Lawrence scale >2)
  • Inflammatory diseases (i.e. rheumatoid arthritis)
  • Underlying bleeding disorder or coagulopathy
  • Concominant chondral defects (> 2 ICRS)
  • Cancer patients
  • Pregnancy
  • Patients who will not cooperate with six-month followup
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
15 participants (estimated)
Patient registry
No

Interventions

  • ProcedurePlatelet-rich plasma (PRP) therapy

    Platelet rich plasma (PRP) describes a technique in which platelets are isolated from a sample of a person's own blood using simple cell-separating systems such as centrifugation in order to obtain highly concentrated samples of platelets that can be re-injected into an injury site to promote healing.

06

What researchers measure

Primary outcomes

  1. Knee injury and Osteoarthritis Outcome Score scale

    Time frame: 6months post procedure

  2. Visual Analog Scale

    Time frame: 6months post procedure

Secondary outcomes

  1. International Knee Documentation Committee - Subjective Knee Evaluation Form

    Time frame: 6months post procedure

  2. Satisfaction Level

    Time frame: 6months post procedure

07

Study locations

1 of 1 sites recruiting
  • Ivan Medina-Porqueres
    Malaga, Spain
    • Ivan Medina-Porqueres, Professor · Contact · imp@uma.es · 0034951952858
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 31, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04040283
Lead sponsor
University of Malaga
Responsible party
Ivan Medina-Porqueres (Professor, University of Malaga) — Principal investigator
First posted
Jul 31, 2019
Start date
Jan 2014
Primary completion
Jan 2019
Completion
Nov 2019 (estimated)
Last update
Jul 31, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

University of Malaga

Start the discussion